BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Rumored Pfizer (PFE) Deal to Buy Cellectis (ALCLS) for $1.64 Billion Could Lock in CRISPR and CAR T Tech     5/29/2015
Rapamune, Pfizer (PFE)'s Branding-Troubled Drug, Gets FDA Approval for Rare Lung Disease     5/29/2015
Celldex (CLDX)'s Brain Cancer Drug Rintega Will Take Center Stage at ASCO     5/29/2015
Bay Area's Heron (HRTX) Rockets as Nausea Drug Meets Goals in Phase III Study     5/29/2015
ASCO15 EXCLUSIVE: Onxeo Will Run Phase III Trial For Oral Mucositis By End of 2015, CEO Tells BioSpace (DHX)     5/29/2015
ASCO15 EXCLUSIVE: Late-Breaking Bristol-Myers Squibb (BMY) Data Renew Tumor Drug Hopes     5/29/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/28/2015
Gilead (GILD)’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts     5/28/2015
Investors Wait With Bated Breath for ImmunoGen (IMGN)'s Ovarian Cancer Drug ASCO News     5/28/2015
Editas Medicine, Juno Therapeutics (JUNO) Hammer Out $727 Million CAR T R&D Deal     5/28/2015
bluebird bio (BLUE) Pads CAR T Arsenal With $131.5 Million Five Prime (FPRX) Pact     5/28/2015
Your Analyst-Vetted Guide to the Five Blockbuster Drugs the FDA May Approve This Summer     5/28/2015
ASCO’s Most Important Abstracts: BioSpace (DHX)’s Cheat Sheet for You     5/28/2015
Gilead (GILD), GlobeImmune (GBIM)'s Hep B Drug Flunks Phase II Study     5/27/2015
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each     5/27/2015
 Featured Stories
ASCO15: Green Tea May Help Prevent Prostate Cancer     5/29/2015
Why The University of Minnesota Research Scandal Threatens Us All     5/28/2015
Hallucinations And Delusions More Common Than Thought, University of Queensland Study     5/28/2015
Betting On Cancer Treatment? Keep An Eye On This Company     5/27/2015
Fetal Cells Injected Into A Man's Brain To Cure His Parkinson's, University of Cambridge Study     5/27/2015
Here’s Why Living On A Noisy Street Could Make You Fatter, Karolinska Institute Study     5/27/2015
California Scientists Test Ecstasy As Anxiety-Reducer For Gravely Ill     5/27/2015
Probiotics May Help Ease Allergies, Vanderbilt University Study Shows     5/27/2015
New Book Claims Grunenthal GmbH Knew About Thalidomide Risk Six Months Before Drug Was Pulled     5/26/2015
Memory Loss Not Always First Sign Of Alzheimer’s, National Hospital For Neurology And Neurosurgery Study     5/26/2015
Teenage Obesity May Double Bowel Cancer Risk, Harvard School of Public Health Study     5/26/2015
Faster Heart Rate Linked To Diabetes Risk, Penn State University Study     5/26/2015
Drinking Coffee May Lower Erectile Dysfunction Risk, University of Texas Health Science Center Study     5/22/2015
Earlier Puberty And Stunted Growth In Boys Linked To Pot Use, Pir Mehr Ali Shah Agriculture University Rawalpindi Study     5/22/2015
Paracetamol Risk To Unborn Boys, University of Edinburgh Study     5/22/2015
 More News
AstraZeneca PLC (AZN) and Eli Lilly (LLY) Ban Together to Test New Cancer Drug Combo     5/29/2015
Amgen (AMGN) CKD Drug Effective in Reducing PTH in Two Phase III Studies     5/29/2015
Positive Results From ChemoCentryx, Inc. (CCXI) Phase II Diabetic Nephropathy Trial With Chemokine Receptor CCR2 Inhibitor CCX140 Highlighted At The 52nd ERA-EDTA Congress     5/29/2015
ASCO15: Affimed Therapeutics AG (AFMD) ASCO Data Demonstrate Consistent Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators     5/29/2015
ASCO15: Heat Biologics To Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 In Advanced NSCLC At ASCO     5/29/2015
Alkermes (ALKS) To Present Clinical Data On ALKS 8700 At Annual Meeting Of The Consortium Of Multiple Sclerosis Centers     5/29/2015
Stemline Therapeutics, Inc. (STML) Announces Top-Line Results From Lead-In Stage Of Ongoing BPDCN Pivotal Trial     5/29/2015
Astute Medical Relelase: In New Cardiac Surgery Study NephroCheck Kidney Biomarkers Rise To The Occasion     5/29/2015
ASCO15: Affimed Therapeutics AG (AFMD) ASCO Data For The CD33/CD3-Tandab Program Demonstrate That CD33 And CD3 Binding Affinities Correlate With Potent T-Cell Activation And Cytotoxicity     5/29/2015
Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online In Antiviral Research     5/29/2015
PharmaCyte Biotech (NVLX) To Conduct Additional Study On Malignant Ascites     5/29/2015
Epic Sciences Release: Genetic Analysis Of Single Circulating Tumor Cells Shows High Intra-Patient Heterogeneity     5/29/2015
Amgen (AMGN) And Merck & Co. (MRK) Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec In Combination With KEYTRUDA (Pembrolizumab) In Patients With Head And Neck Cancer     5/29/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Enters Into Research Collaboration To Investigate Novel PS-Targeting Immunotherapy Combinations     5/29/2015
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In France By Laboratoires Majorelle     5/29/2015